2008
DOI: 10.1016/j.diabet.2008.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
25
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 34 publications
4
25
0
Order By: Relevance
“…Consequently, hypertension and NSAID treatment were correlated to mGFR, but including NSAID treatment as a factor in the multiple regression analysis also improved the accuracy in estimating GFR in the cancer patients. In agreement with previous studies [14], the data show that diabetes was biased in the CG and MDRD equations. Furthermore, height, weight, age and hypertension were biased in the CG, MDRD and CKD-EPI equations.…”
Section: Discussionsupporting
confidence: 81%
“…Consequently, hypertension and NSAID treatment were correlated to mGFR, but including NSAID treatment as a factor in the multiple regression analysis also improved the accuracy in estimating GFR in the cancer patients. In agreement with previous studies [14], the data show that diabetes was biased in the CG and MDRD equations. Furthermore, height, weight, age and hypertension were biased in the CG, MDRD and CKD-EPI equations.…”
Section: Discussionsupporting
confidence: 81%
“…An increase in glomerular filtration rate leads to an increase in cystatin C filtration and a decrease in its serum concentration. Participants with kidney and heart disease were excluded from the analysis because renal and heart disease are associated with an elevated serum cystatin (Bökenkamp et al 2006;Narvaez-Sanchez et al 2008;Rigalleau et al 2008). An additional 13% of the potential participants were excluded because they had missing information about their important cardiovascular risk factors.…”
Section: Discussionmentioning
confidence: 99%
“…To date, UAE remains the universally accepted biomarker in clinical practice [31]. One promising new biomarker is cystatin C, a cysteine protease inhibitor that is increased in serum and urine of patients with DN [32][33][34]. Cystatin C is increased Fig.…”
Section: Discussionmentioning
confidence: 99%